Glonghui, May 14 | The US stock of Novavax Pharmaceuticals (NVAX.US), which had surged nearly 200% on the previous 2 days, continued to rise 4% before the market to $13.64. According to the news, the stock price of Novavax Pharmaceuticals, which once fell into “business difficulties” after the COVID-19 vaccine faded away, had risen nearly 50% as of Monday, with a cumulative increase of nearly 200% over the two trading days since last Friday. Wall Street investors are delighted and encouraged that the company has reached a new deal of over 1 billion US dollars with French pharmaceutical giant Sanofi.
美股异动｜诺瓦瓦克斯医药盘前继续上涨4% 此前2日飙涨近200%
Changes in US stocks | Novavax Pharmaceuticals continued to rise 4% before the market and surged nearly 200% in the previous 2 days
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.